PLoS ONE (Jan 2014)

Microarray analysis of cell cycle gene expression in adult human corneal endothelial cells.

  • Binh Minh Ha Thi,
  • Nelly Campolmi,
  • Zhiguo He,
  • Aurélien Pipparelli,
  • Chloé Manissolle,
  • Jean-Yves Thuret,
  • Simone Piselli,
  • Fabien Forest,
  • Michel Peoc'h,
  • Olivier Garraud,
  • Philippe Gain,
  • Gilles Thuret

DOI
https://doi.org/10.1371/journal.pone.0094349
Journal volume & issue
Vol. 9, no. 4
p. e94349

Abstract

Read online

Corneal endothelial cells (ECs) form a monolayer that controls the hydration of the cornea and thus its transparency. Their almost nil proliferative status in humans is responsible, in several frequent diseases, for cell pool attrition that leads to irreversible corneal clouding. To screen for candidate genes involved in cell cycle arrest, we studied human ECs subjected to various environments thought to induce different proliferative profiles compared to ECs in vivo. Donor corneas (a few hours after death), organ-cultured (OC) corneas, in vitro confluent and non-confluent primary cultures, and an immortalized EC line were compared to healthy ECs retrieved in the first minutes of corneal grafts. Transcriptional profiles were compared using a cDNA array of 112 key genes of the cell cycle and analysed using Gene Ontology classification; cluster analysis and gene map presentation of the cell cycle regulation pathway were performed by GenMAPP. Results were validated using qRT-PCR on 11 selected genes. We found several transcripts of proteins implicated in cell cycle arrest and not previously reported in human ECs. Early G1-phase arrest effectors and multiple DNA damage-induced cell cycle arrest-associated transcripts were found in vivo and over-represented in OC and in vitro ECs. Though highly proliferative, immortalized ECs also exhibited overexpression of transcripts implicated in cell cycle arrest. These new effectors likely explain the stress-induced premature senescence that characterizes human adult ECs. They are potential targets for triggering and controlling EC proliferation with a view to increasing the cell pool of stored corneas or facilitating mass EC culture for bioengineered endothelial grafts.